You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Why sac regression?
Endurant™ AAA stent graft has demonstrated low type I and type II endoleaks in broad patient anatomies, with3,4:
See the features and benefits of the Endurant II/IIs system in action. - (02:25)
Methodology:
Radial force and micro-CT scans were tested by an independent lab to model Endurant's performance in the proximal seal zone through the cardiac cycle.
Results:
M-stent maintains even distribution of contact pressure, resulting in optimal conformability in a pulsatile environment.
See the Endurant II/IIs system perform in a dynamic environment.*
*Medtronic data on file.
†Bench test data may not be indicative of clinical performance. Performance may vary upon use. Medtronic data on file.
Aneurysm sac regression is a key indicator2 for EVAR success.
Dr. Ross Milner, Professor of Surgery, Co-director, Center for Aortic Diseases at the University of Chicago, discusses his thoughts on aneurysm sac regression post-EVAR.
Sac Regression and EVAR Success Video - (01:55)
Watch the video to see Dr. Ross Milner discuss aneurysm sac regression as a key indicator for EVAR success.
More information (see more)
Less information (see less)
Hear physicians' thoughts on aneurysm sac regression post-EVAR ― watch the on-demand webcast.
"If you have sac shrinkage in the first year, the need for secondary interventions and therefore the need for intensive follow-up is different than those that don’t shrink." –Prof. Hence Verhagen
Aneurysm Sac Regression Post-EVAR Webinar - (05:37)
Watch physicians discuss their thoughts on aneurysm sac regression post-EVAR.
More information (see more)
Less information (see less)
ENGAGE OUS registry confirms sac regression link to better long-term outcomes. Patients with regressing sacs at 1 year had statistically significant better FF from ACM and FF from secondary endovascular reinterventions than patients with stable or expanding sacs.6
Endurant demonstrates consistent and high sac regression rates across straightforward and complex anatomies.
New data suggests that patients with sac regression at 1 year appear to continue to have sac regression at 5 years.*
Dr. Ross Milner reviews the case of a challenging EVAR patient that resulted in a regressing aneurysm sac.
Challenging EVAR Procedure - (04:00)
Watch the video to see Dr. Ross Milner review the case of a challenging EVAR patient which resulted in a regressing aneurysm sac.
More information (see more)
Less information (see less)
Medtronic data on file.
Bench test data may not be indicative of clinical performance. Performance may vary upon use. Medtronic data on file.
P < 0.01 for comparisons to the Regression group.
Sac regression defined as the reduction in maximum diameter of the aneurysm sac by ≥ 5 mm for the ENGAGE OUS Registry Full Cohort. Other studies cited use a threshold of > 5 mm.
Medtronic data on file (PASR 2020).
Ahn SS, Rutherford RB, Johnston KW, et al. Reporting standards for infrarenal endovascular abdominal aortic aneurysm repair. Ad Hoc Committee for Standardized Reporting Practices in Vascular Surgery of The Society for Vascular Surgery/International Society for Cardiovascular Surgery. J Vasc Surg. February 1997;25(2):405-410.
O’Donnell TFX, Deery SE, Boitano LT, et al. Aneurysm sac failure to regress after endovascular aneurysm repair is associated with lower long-term survival. J Vasc Surg. February 2019;69(2):414-422.
Singh MJ, Fairman R, Anain P, et al. Final Results of the Endurant Stent Graft System in the United States regulatory trial. J Vasc Surg. July 2016;64(1):55-62.
Teijink JAW, Power AH, Böckler D, et al. Editor's Choice - Five Year Outcomes of the Endurant Stent Graft for Endovascular Abdominal Aortic Aneurysm Repair in the ENGAGE Registry. Eur J Vasc Endovasc Surg. August 2019;58(2):175-181.
Wakefield TW, Shulkin BL, Fellows EP, Petry NA, Spaulding SA, Stanley JC. Platelet reactivity in human aortic grafts: a prospective, randomized midterm study of platelet adherence and release products in Dacron and polytetrafluoroethylene conduits. J Vasc Surg. February 1989;9(2):234-243.
Bӧckler D, Li C, Dansey K, et al. Sac regression is associated with lower all-cause mortality after contemporary endovascular aneurysm repair — a new paradigm for success. Presented online at ESVS 34th Annual Meeting, October 6, 2020.